293 related articles for article (PubMed ID: 18036641)
1. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer.
Greenaway J; Moorehead R; Shaw P; Petrik J
Gynecol Oncol; 2008 Feb; 108(2):385-94. PubMed ID: 18036641
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ID8 MOSE and VEGF-modified ID8 cell lines in an immunocompetent animal model for human ovarian cancer.
Janát-Amsbury MM; Yockman JW; Anderson ML; Kieback DG; Kim SW
Anticancer Res; 2006; 26(4B):2785-9. PubMed ID: 16886597
[TBL] [Abstract][Full Text] [Related]
3. Alpha-lipoic acid modulates ovarian surface epithelial cell growth.
Vig-Varga E; Benson EA; Limbil TL; Allison BM; Goebl MG; Harrington MA
Gynecol Oncol; 2006 Oct; 103(1):45-52. PubMed ID: 16574204
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model.
Hu L; Hofmann J; Holash J; Yancopoulos GD; Sood AK; Jaffe RB
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6966-71. PubMed ID: 16203789
[TBL] [Abstract][Full Text] [Related]
5. Combination of local, non-viral IL12 gene therapy and systemic paclitaxel chemotherapy in a syngeneic ID8 mouse model for human ovarian cancer.
Janát-Amsbury MM; Yockman JW; Anderson ML; Kieback DG; Kim SW
Anticancer Res; 2006; 26(5A):3223-8. PubMed ID: 17094433
[TBL] [Abstract][Full Text] [Related]
6. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.
Connolly DC; Bao R; Nikitin AY; Stephens KC; Poole TW; Hua X; Harris SS; Vanderhyden BC; Hamilton TC
Cancer Res; 2003 Mar; 63(6):1389-97. PubMed ID: 12649204
[TBL] [Abstract][Full Text] [Related]
7. The impact of the ovarian microenvironment on the anti-tumor effect of SPARC on ovarian cancer.
Greenaway JB; Koehler A; McCulloch CA; Petrik J; Brown TJ; Ringuette MJ
Biochem Cell Biol; 2012 Feb; 90(1):96-107. PubMed ID: 22003835
[TBL] [Abstract][Full Text] [Related]
8. Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model.
Hashimoto K; Morishige K; Sawada K; Tahara M; Kawagishi R; Ikebuchi Y; Sakata M; Tasaka K; Murata Y
Cancer Res; 2005 Jan; 65(2):540-5. PubMed ID: 15695397
[TBL] [Abstract][Full Text] [Related]
9. [Biological characteristics of an established model of ovarian cancer in mice and its homologous cell lines].
Zhang ZM; Zhang C; Zhang FH; Shan BE; Nakagawa S
Ai Zheng; 2006 Jun; 25(6):701-7. PubMed ID: 16764764
[TBL] [Abstract][Full Text] [Related]
10. Immunocompetent orthotopic isograft mouse model of ovarian cancer for high-intensity focused ultrasound (HIFU) treatment.
Chou ST; Rabkin BA; Dowling S; Vaezy S; Theiss P
Comp Med; 2004 Dec; 54(6):645-51. PubMed ID: 15679262
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line.
Sylvain V; Lafarge S; Bignon YJ
Int J Oncol; 2002 Apr; 20(4):845-53. PubMed ID: 11894135
[TBL] [Abstract][Full Text] [Related]
12. Expression and functions of transmembrane mucin MUC13 in ovarian cancer.
Chauhan SC; Vannatta K; Ebeling MC; Vinayek N; Watanabe A; Pandey KK; Bell MC; Koch MD; Aburatani H; Lio Y; Jaggi M
Cancer Res; 2009 Feb; 69(3):765-74. PubMed ID: 19176398
[TBL] [Abstract][Full Text] [Related]
13. Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer.
Shaw TJ; Senterman MK; Dawson K; Crane CA; Vanderhyden BC
Mol Ther; 2004 Dec; 10(6):1032-42. PubMed ID: 15564135
[TBL] [Abstract][Full Text] [Related]
14. Normalization of the ovarian cancer microenvironment by SPARC.
Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
[TBL] [Abstract][Full Text] [Related]
15. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic stellate cells: partners in crime with pancreatic cancer cells.
Vonlaufen A; Joshi S; Qu C; Phillips PA; Xu Z; Parker NR; Toi CS; Pirola RC; Wilson JS; Goldstein D; Apte MV
Cancer Res; 2008 Apr; 68(7):2085-93. PubMed ID: 18381413
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
18. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.
Mills GB; May C; Hill M; Campbell S; Shaw P; Marks A
J Clin Invest; 1990 Sep; 86(3):851-5. PubMed ID: 2394835
[TBL] [Abstract][Full Text] [Related]
19. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice.
Robinson-Smith TM; Isaacsohn I; Mercer CA; Zhou M; Van Rooijen N; Husseinzadeh N; McFarland-Mancini MM; Drew AF
Cancer Res; 2007 Jun; 67(12):5708-16. PubMed ID: 17575137
[TBL] [Abstract][Full Text] [Related]
20. [Epithelial ovarian tumor microecology].
Leroy-Dudal J; Kellouche S; Gauduchon P; Carreiras F
Bull Cancer; 2008 Sep; 95(9):829-39. PubMed ID: 18829416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
